University Health Network-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

2019

  1. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    The Lancet Neurology, Vol. 18, Núm. 1, pp. 46-55

2015

  1. Healthcare engineering defined: A white paper

    Journal of Healthcare Engineering, Vol. 6, Núm. 4, pp. 635-648

2014

  1. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

    Breast Cancer Research, Vol. 16

  2. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    PLoS Genetics, Vol. 10, Núm. 4

2011

  1. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

    BMC Infectious Diseases, Vol. 11

  2. Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza

    Critical Care

2010

  1. Host adaptive immunity deficiency in severe pandemic influenza

    Critical Care, Vol. 14, Núm. 5

2009

  1. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

    Journal of Infection in Developing Countries, Vol. 3, Núm. 3, pp. 159-161

  2. Nasopharyngeal aspirate cytokine levels 1 yr after severe respiratory syncytial virus infection

    Pediatric Allergy and Immunology, Vol. 20, Núm. 8, pp. 791-795

  3. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza

    Critical Care, Vol. 13, Núm. 6

2007

  1. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children

    Journal of Allergy and Clinical Immunology